These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 34432564)

  • 41. Teaching old mice new tricks: the utility of aged mouse models of C. difficile infection to study pathogenesis and rejuvenate immune response.
    Shin JH; Pawlowski SW; Warren CA
    Gut Microbes; 2021; 13(1):1966255. PubMed ID: 34432545
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cathelicidin aggravates myocardial ischemia/reperfusion injury via activating TLR4 signaling and P2X
    Wu Y; Zhang Y; Zhang J; Zhai T; Hu J; Luo H; Zhou H; Zhang Q; Zhou Z; Liu F
    J Mol Cell Cardiol; 2020 Feb; 139():75-86. PubMed ID: 31982429
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Butyrate Protects Mice from Clostridium difficile-Induced Colitis through an HIF-1-Dependent Mechanism.
    Fachi JL; Felipe JS; Pral LP; da Silva BK; Corrêa RO; de Andrade MCP; da Fonseca DM; Basso PJ; Câmara NOS; de Sales E Souza ÉL; Dos Santos Martins F; Guima SES; Thomas AM; Setubal JC; Magalhães YT; Forti FL; Candreva T; Rodrigues HG; de Jesus MB; Consonni SR; Farias ADS; Varga-Weisz P; Vinolo MAR
    Cell Rep; 2019 Apr; 27(3):750-761.e7. PubMed ID: 30995474
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tryptophan catabolism restricts IFN-γ-expressing neutrophils and Clostridium difficile immunopathology.
    El-Zaatari M; Chang YM; Zhang M; Franz M; Shreiner A; McDermott AJ; van der Sluijs KF; Lutter R; Grasberger H; Kamada N; Young VB; Huffnagle GB; Kao JY
    J Immunol; 2014 Jul; 193(2):807-16. PubMed ID: 24935925
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The protective effect of recombinant Lactococcus lactis oral vaccine on a Clostridium difficile-infected animal model.
    Yang XQ; Zhao YG; Chen XQ; Jiang B; Sun DY
    BMC Gastroenterol; 2013 Jul; 13():117. PubMed ID: 23865596
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Favorable interleukin-8 induction in human gingival epithelial cells by the antimicrobial peptide LL-37.
    Montreekachon P; Nongparn S; Sastraruji T; Khongkhunthian S; Chruewkamlow N; Kasinrerk W; Krisanaprakornkit S
    Asian Pac J Allergy Immunol; 2014 Sep; 32(3):251-60. PubMed ID: 25268344
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Host immunity to Clostridium difficile PCR ribotype 017 strains.
    Jafari NV; Songane M; Stabler RA; Elawad M; Wren BW; Allan E; Bajaj-Elliott M
    Infect Immun; 2014 Dec; 82(12):4989-96. PubMed ID: 25225246
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The insect peptide coprisin prevents Clostridium difficile-mediated acute inflammation and mucosal damage through selective antimicrobial activity.
    Kang JK; Hwang JS; Nam HJ; Ahn KJ; Seok H; Kim SK; Yun EY; Pothoulakis C; Lamont JT; Kim H
    Antimicrob Agents Chemother; 2011 Oct; 55(10):4850-7. PubMed ID: 21807975
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The dual role of cathelicidins in systemic inflammation.
    Pinheiro da Silva F; Machado MC
    Immunol Lett; 2017 Feb; 182():57-60. PubMed ID: 28082134
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Markers of intestinal inflammation, not bacterial burden, correlate with clinical outcomes in Clostridium difficile infection.
    El Feghaly RE; Stauber JL; Deych E; Gonzalez C; Tarr PI; Haslam DB
    Clin Infect Dis; 2013 Jun; 56(12):1713-21. PubMed ID: 23487367
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clostridioides difficile exploits toxin-mediated inflammation to alter the host nutritional landscape and exclude competitors from the gut microbiota.
    Fletcher JR; Pike CM; Parsons RJ; Rivera AJ; Foley MH; McLaren MR; Montgomery SA; Theriot CM
    Nat Commun; 2021 Jan; 12(1):462. PubMed ID: 33469019
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Type 2 cytokines IL-4 and IL-5 reduce severe outcomes from Clostridiodes difficile infection.
    Donlan AN; Simpson ME; Petri WA
    Anaerobe; 2020 Dec; 66():102275. PubMed ID: 32971206
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clostridium difficile-induced colitis in mice is independent of leukotrienes.
    Trindade BC; Theriot CM; Leslie JL; Carlson PE; Bergin IL; Peters-Golden M; Young VB; Aronoff DM
    Anaerobe; 2014 Dec; 30():90-8. PubMed ID: 25230329
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Systemic Inflammatory Mediators Are Effective Biomarkers for Predicting Adverse Outcomes in Clostridioides difficile Infection.
    Dieterle MG; Putler R; Perry DA; Menon A; Abernathy-Close L; Perlman NS; Penkevich A; Standke A; Keidan M; Vendrov KC; Bergin IL; Young VB; Rao K
    mBio; 2020 May; 11(3):. PubMed ID: 32371595
    [No Abstract]   [Full Text] [Related]  

  • 55. Aging Dampens the Intestinal Innate Immune Response during Severe Clostridioides difficile Infection and Is Associated with Altered Cytokine Levels and Granulocyte Mobilization.
    Abernathy-Close L; Dieterle MG; Vendrov KC; Bergin IL; Rao K; Young VB
    Infect Immun; 2020 May; 88(6):. PubMed ID: 32284366
    [No Abstract]   [Full Text] [Related]  

  • 56. Role of the intestinal microbiota in resistance to colonization by Clostridium difficile.
    Britton RA; Young VB
    Gastroenterology; 2014 May; 146(6):1547-53. PubMed ID: 24503131
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection Enhances Adaptive Immunity to C difficile Toxin B.
    Cook L; Rees WD; Wong MQ; Peters H; Levings MK; Steiner TS
    Gastroenterology; 2021 May; 160(6):2155-2158.e4. PubMed ID: 33444574
    [No Abstract]   [Full Text] [Related]  

  • 58. Ciprofloxacin Affects Host Cells by Suppressing Expression of the Endogenous Antimicrobial Peptides Cathelicidins and Beta-Defensin-3 in Colon Epithelia.
    Sarker P; Mily A; Mamun AA; Jalal S; Bergman P; Raqib R; Gudmundsson GH; Agerberth B
    Antibiotics (Basel); 2014 Jul; 3(3):353-74. PubMed ID: 27025750
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cefoperazone-treated mice as an experimental platform to assess differential virulence of Clostridium difficile strains.
    Theriot CM; Koumpouras CC; Carlson PE; Bergin II; Aronoff DM; Young VB
    Gut Microbes; 2011; 2(6):326-34. PubMed ID: 22198617
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Complement and IL-22: partnering up for border patrol.
    Yamamoto H; Kemper C
    Immunity; 2014 Oct; 41(4):511-3. PubMed ID: 25367566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.